Identification and validation of the methylation biomarkers of non-small cell lung cancer (NSCLC).
about
Genome-wide epigenomic profiling for biomarker discoveryIntegrated analysis of promoter methylation and expression of telomere related genes in breast cancer.Diverse expression patterns and tumorigenic role of neurotensin signaling components in colorectal cancer cells.Quantitative analysis of mRNA expression levels and DNA methylation profiles of three neighboring genes: FUS1, NPRL2/G21 and RASSF1A in non-small cell lung cancer patients.Differentially expressed and activated proteins associated with non small cell lung cancer tissuesELMO3 is a novel biomarker for diagnosis and prognosis of non-small cell lung cancerAn integrative study on the impact of highly differentially methylated genes on expression and cancer etiologyEpigenetic silencing of NTSR1 is associated with lateral and noninvasive growth of colorectal tumors.Prognostic value of aberrant promoter hypermethylation of tumor-related genes in early-stage head and neck cancer.Integrated analysis of genome-wide DNA methylation and gene expression profiles identifies potential novel biomarkers of rectal cancer.Identification of Methylation-Driven, Differentially Expressed STXBP6 as a Novel Biomarker in Lung Adenocarcinoma.Accumulated promoter methylation as a potential biomarker for esophageal cancer.Genome-wide DNA methylation patterns in CD4+ T cells from Chinese Han patients with rheumatoid arthritis.Aberrant gene-specific DNA methylation signature analysis in cervical cancer.AGTR1 promoter hypermethylation in lung squamous cell carcinoma but not in lung adenocarcinoma.Targeted bisulfite sequencing identified a panel of DNA methylation-based biomarkers for esophageal squamous cell carcinoma (ESCC).Applications of Support Vector Machine (SVM) Learning in Cancer Genomics.Analysis of RTEL1 and PCDHGB6 promoter methylation in circulating-free DNA of lung cancer patients using liquid biopsy: A pilot study.Role of the SOX18 protein in neoplastic processes
P2860
Q28080102-60B6F511-AD2C-4024-BE50-3F4A1BE94AF2Q33648900-15924A03-B961-4903-8C39-28C53FEF535EQ33699404-B06B9E10-CBF0-4F98-8714-69940BF3357CQ35794392-F34B6BA7-CBDF-4E07-BC16-5539144248E1Q35805319-13E2CCBB-77FA-41E2-BE32-B7B8FAA38B13Q35854232-B9BBBCAF-582A-43F2-8D98-4174BE8A3333Q36274178-ABB5EBDD-CC6F-4E95-90F7-EFED09A76181Q36557481-3BBB9058-2891-453A-A66A-12A65973836AQ37295588-6594BB60-4EB1-442F-AF77-E22E111E9329Q37641812-B7E865DE-3EA1-4E06-86A6-AA89CD30CA98Q37642592-1681F337-41EA-46FD-A51D-48E40FB66C30Q37702338-655FFCB6-DFFF-4FB6-898B-6FC498592528Q38443150-09373F37-C679-4E7A-AE30-884D6DC2F0EBQ38870688-488CCB25-87B7-456E-906E-4C34055AA9E6Q47131287-290D6AAB-691B-4514-84E2-9079507E660BQ47139531-94388A5A-6FEB-4EE2-A933-FBD4CC5A3EA1Q47173069-F3EA778C-BE28-46C8-B9FA-9C2F87B6B1E2Q51477838-01595DE2-C6F6-4C64-BD11-8FDC1BAC6653Q57173334-3F415D3D-2139-4D5E-A47A-AE06CEAC3962
P2860
Identification and validation of the methylation biomarkers of non-small cell lung cancer (NSCLC).
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Identification and validation ...... mall cell lung cancer (NSCLC).
@ast
Identification and validation ...... mall cell lung cancer (NSCLC).
@en
type
label
Identification and validation ...... mall cell lung cancer (NSCLC).
@ast
Identification and validation ...... mall cell lung cancer (NSCLC).
@en
prefLabel
Identification and validation ...... mall cell lung cancer (NSCLC).
@ast
Identification and validation ...... mall cell lung cancer (NSCLC).
@en
P2093
P2860
P1433
P1476
Identification and validation ...... mall cell lung cancer (NSCLC).
@en
P2093
Fengyang Yan
Jiucun Wang
Momiao Xiong
Xiaofeng Chen
Xiaotian Wang
P2860
P2888
P356
10.1186/S13148-014-0035-3
P50
P577
2015-01-22T00:00:00Z
P5875
P6179
1030604417